May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced...
May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced...
May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that Prospect purchased $64.5 million of first lien senior secured floating rate notes issued by RME Group Holding...
May 10, 2017 11:01 am UTC| Business
NEW YORK, May 10, 2017 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that Prospect purchased $64.5 million of first lien senior secured floating rate notes issued by RME Group Holding...
Broadridge Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2017
May 10, 2017 11:01 am UTC| Business
Third quarter recurring fee revenue up 30%; Adjusted EPS up 19%; and YTD Closed sales up 33% Strong third quarter puts Broadridge on track to achieve full year guidance for recurring fee revenues, Adjusted EPS and Closed...
Broadridge Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2017
May 10, 2017 11:01 am UTC| Business
Third quarter recurring fee revenue up 30%; Adjusted EPS up 19%; and YTD Closed sales up 33% Strong third quarter puts Broadridge on track to achieve full year guidance for recurring fee revenues, Adjusted EPS and Closed...
May 10, 2017 11:01 am UTC| Business
ALPHARETTA, Ga., May 10, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today reported financial...